Jul.01 -- An early trial of an experimental coronavirus vaccine from Pfizer Inc. and BioNtech SE showed it’s safe and prompted patients to produce antibodies against the new virus, keeping it in the lead pack for a pandemic shot. Sam Fazeli of Bloomberg Intelligence discusses the report on "Bloomberg Markets."
Ещё видео!